TET2 and chronic myelomonocytic leukemia: Mono- or bi-allelic somatic mutations along the entire coding TET2 region are recurrent events in human hematopoietic malignancies17,18, especially in chronic myelomonocytic leukemia (CMML) in which mono- or bi-allelic mutations in TET2 gene are detected in 57% of patients19.